
### [NCIT:C27357](http://purl.obolibrary.org/obo/NCIT_C27357)
**Label:** Refractory Hematologic Malignancy

**Subclasses:** [NCIT:C4997](http://purl.obolibrary.org/obo/NCIT_C4997) (Refractory Nodal Marginal Zone Lymphoma), [NCIT:C8836](http://purl.obolibrary.org/obo/NCIT_C8836) (Refractory Hodgkin Lymphoma), [NCIT:C7227](http://purl.obolibrary.org/obo/NCIT_C7227) (Refractory T Lymphoblastic Lymphoma), [NCIT:C7228](http://purl.obolibrary.org/obo/NCIT_C7228) (Refractory Mature B-Cell Non-Hodgkin Lymphoma), [NCIT:C8833](http://purl.obolibrary.org/obo/NCIT_C8833) (Refractory Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C8875](http://purl.obolibrary.org/obo/NCIT_C8875) (Refractory Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C134154](http://purl.obolibrary.org/obo/NCIT_C134154) (Refractory Lymphoma), [NCIT:C8870](http://purl.obolibrary.org/obo/NCIT_C8870) (Refractory B Lymphoblastic Lymphoma), [NCIT:C8671](http://purl.obolibrary.org/obo/NCIT_C8671) (Refractory Angioimmunoblastic T-cell Lymphoma), [NCIT:C5090](http://purl.obolibrary.org/obo/NCIT_C5090) (Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C134319](http://purl.obolibrary.org/obo/NCIT_C134319) (Refractory Acute Myeloid Leukemia), [NCIT:C134835](http://purl.obolibrary.org/obo/NCIT_C134835) (Refractory Ph-Like Acute Lymphoblastic Leukemia), [NCIT:C8927](http://purl.obolibrary.org/obo/NCIT_C8927) (Refractory Centroblastic Lymphoma), [NCIT:C8847](http://purl.obolibrary.org/obo/NCIT_C8847) (Refractory Burkitt Lymphoma), [NCIT:C8846](http://purl.obolibrary.org/obo/NCIT_C8846) (Refractory Small Lymphocytic Lymphoma), [NCIT:C138028](http://purl.obolibrary.org/obo/NCIT_C138028) (Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type), [NCIT:C136488](http://purl.obolibrary.org/obo/NCIT_C136488) (Refractory Acute Lymphoblastic Leukemia), [NCIT:C8689](http://purl.obolibrary.org/obo/NCIT_C8689) (Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma), [NCIT:C136489](http://purl.obolibrary.org/obo/NCIT_C136489) (Refractory Erdheim-Chester Disease), [NCIT:C9339](http://purl.obolibrary.org/obo/NCIT_C9339) (Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified), [NCIT:C8687](http://purl.obolibrary.org/obo/NCIT_C8687) (Refractory Mycosis Fungoides), [NCIT:C138024](http://purl.obolibrary.org/obo/NCIT_C138024) (Refractory Breast Lymphoma), [NCIT:C8842](http://purl.obolibrary.org/obo/NCIT_C8842) (Refractory B-Cell Non-Hodgkin Lymphoma), [NCIT:C138026](http://purl.obolibrary.org/obo/NCIT_C138026) (Refractory Intravascular Large B-Cell Lymphoma), [NCIT:C138020](http://purl.obolibrary.org/obo/NCIT_C138020) (Refractory Central Nervous System Lymphoma), [NCIT:C5096](http://purl.obolibrary.org/obo/NCIT_C5096) (Refractory Splenic Marginal Zone Lymphoma), [NCIT:C8681](http://purl.obolibrary.org/obo/NCIT_C8681) (Refractory Enteropathy-Associated T-Cell Lymphoma), [NCIT:C138022](http://purl.obolibrary.org/obo/NCIT_C138022) (Refractory Testicular Lymphoma), [NCIT:C133736](http://purl.obolibrary.org/obo/NCIT_C133736) (Refractory Classical Hodgkin Lymphoma), [NCIT:C8938](http://purl.obolibrary.org/obo/NCIT_C8938) (Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma), [NCIT:C8858](http://purl.obolibrary.org/obo/NCIT_C8858) (Refractory Follicular Lymphoma), [NCIT:C134177](http://purl.obolibrary.org/obo/NCIT_C134177) (Refractory Langerhans Cell Histiocytosis), [NCIT:C115458](http://purl.obolibrary.org/obo/NCIT_C115458) (Refractory Childhood Hodgkin Lymphoma), [NCIT:C8658](http://purl.obolibrary.org/obo/NCIT_C8658) (Refractory Anaplastic Large Cell Lymphoma), [NCIT:C7886](http://purl.obolibrary.org/obo/NCIT_C7886) (Refractory Chronic Lymphocytic Leukemia), [NCIT:C8853](http://purl.obolibrary.org/obo/NCIT_C8853) (Refractory Diffuse Large B-Cell Lymphoma), [NCIT:C8652](http://purl.obolibrary.org/obo/NCIT_C8652) (Refractory Lymphoplasmacytic Lymphoma), [NCIT:C7885](http://purl.obolibrary.org/obo/NCIT_C7885) (Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C8696](http://purl.obolibrary.org/obo/NCIT_C8696) (Refractory T Lymphoblastic Leukemia/Lymphoma), [NCIT:C138014](http://purl.obolibrary.org/obo/NCIT_C138014) (Refractory B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma), [NCIT:C8650](http://purl.obolibrary.org/obo/NCIT_C8650) (Refractory Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C122624](http://purl.obolibrary.org/obo/NCIT_C122624) (Refractory Childhood Acute Lymphoblastic Leukemia), [NCIT:C126309](http://purl.obolibrary.org/obo/NCIT_C126309) (Refractory Adult Acute Lymphoblastic Leukemia), [NCIT:C134168](http://purl.obolibrary.org/obo/NCIT_C134168) (Refractory Histiocytic and Dendritic Cell Neoplasm), [NCIT:C7813](http://purl.obolibrary.org/obo/NCIT_C7813) (Refractory Plasma Cell Neoplasm), [NCIT:C8669](http://purl.obolibrary.org/obo/NCIT_C8669) (Refractory Nasal Type Extranodal NK/T-Cell Lymphoma), [NCIT:C8701](http://purl.obolibrary.org/obo/NCIT_C8701) (Refractory Non-Hodgkin Lymphoma), [NCIT:C8664](http://purl.obolibrary.org/obo/NCIT_C8664) (Refractory T-Cell Non-Hodgkin Lymphoma), [NCIT:C8862](http://purl.obolibrary.org/obo/NCIT_C8862) (Refractory Mantle Cell Lymphoma), [NCIT:C8030](http://purl.obolibrary.org/obo/NCIT_C8030) (Refractory Hairy Cell Leukemia), [NCIT:C7260](http://purl.obolibrary.org/obo/NCIT_C7260) (Refractory Nodular Lymphocyte Predominant Hodgkin Lymphoma), 

**Class expressions from DL-Learner:**

- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C43251](http://purl.obolibrary.org/obo/NCIT_C43251) (Histiocytic and Dendritic Cell))) 66.67%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 52.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([CHEBI:23019](http://purl.obolibrary.org/obo/CHEBI_23019) (carbonyl group))) 52.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([CHEBI:23004](http://purl.obolibrary.org/obo/CHEBI_23004) (carbamoyl group))) 52.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([CHEBI:22868](http://purl.obolibrary.org/obo/CHEBI_22868) (bile salt))) 52.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([CHEBI:22563](http://purl.obolibrary.org/obo/CHEBI_22563) (anion))) 52.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([CHEBI:17089](http://purl.obolibrary.org/obo/CHEBI_17089) (glycoprotein))) 52.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([CHEBI:16990](http://purl.obolibrary.org/obo/CHEBI_16990) (bilirubin))) 52.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([CHEBI:16541](http://purl.obolibrary.org/obo/CHEBI_16541) (protein polypeptide chain))) 52.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([CHEBI:16336](http://purl.obolibrary.org/obo/CHEBI_16336) (hyaluronic acid))) 52.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([CHEBI:15440](http://purl.obolibrary.org/obo/CHEBI_15440) (squalene))) 52.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([CHEBI:10545](http://purl.obolibrary.org/obo/CHEBI_10545) (electron))) 52.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not (CARO:0010000)) 52.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([BFO:0000020](http://purl.obolibrary.org/obo/BFO_0000020) (null))) 52.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([BFO:0000019](http://purl.obolibrary.org/obo/BFO_0000019) (null))) 52.02%


